Induction chemoradiotherapy including docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer
出版年份 2020 全文链接
标题
Induction chemoradiotherapy including docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer
作者
关键词
-
出版物
Esophagus
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-01-02
DOI
10.1007/s10388-019-00709-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma
- (2019) Ken Sasaki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Residual carcinoma cells after chemoradiotherapy for esophageal squamous cell carcinoma patients: striving toward appropriate judgment of biopsy
- (2018) F Fujishima et al. DISEASES OF THE ESOPHAGUS
- Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer
- (2018) Hiroshi Okamoto et al. Esophagus
- Residual carcinoma cells after chemoradiotherapy for esophageal squamous cell carcinoma patients: striving toward appropriate judgment of biopsy
- (2018) F Fujishima et al. DISEASES OF THE ESOPHAGUS
- Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2
- (2018) Yuko Kitagawa et al. Esophagus
- Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1
- (2018) Yuko Kitagawa et al. Esophagus
- Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil
- (2018) Yukihisa Tamaki et al. Journal of Cancer
- A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma
- (2016) Hironaga Satake et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Impact of Preoperative Neutrophil to Lymphocyte Ratio and Postoperative Infectious Complications on Survival After Curative Gastrectomy for Gastric Cancer
- (2016) Yasuhiko Mohri et al. MEDICINE
- Japanese Classification of Esophageal Cancer, 11th Edition: part I
- (2016) Esophagus
- Definitive Chemoradiation Therapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-R) in Advanced Esophageal Cancer: A Phase 2 Trial (KDOG 0501-P2)
- (2014) Katsuhiko Higuchi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Three-arm Phase III Trial Comparing Cisplatin Plus 5-FU (CF) Versus Docetaxel, Cisplatin Plus 5-FU (DCF) Versus Radiotherapy with CF (CF-RT) as Preoperative Therapy for Locally Advanced Esophageal Cancer (JCOG1109, NExT Study)
- (2013) Kenichi Nakamura et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Complete Clinical Response After Neoadjuvant Chemoradiotherapy for Squamous Cell Cancer of the Thoracic Oesophagus: Is Surgery Always Necessary?
- (2013) Carlo Castoro et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Role of surgical resection in complete responders on FDG-PET after chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
- (2013) Yuri Jeong et al. JOURNAL OF SURGICAL ONCOLOGY
- Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation
- (2013) K Kono et al. Cell Death & Disease
- Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
- (2012) Manabu Emi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Treatment of T4 Esophageal Cancer. Definitive Chemo-Radiotherapy vs Chemo-Radiotherapy Followed by Surgery
- (2011) Tomoki Makino et al. Annals of Thoracic and Cardiovascular Surgery
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now